Skip to main content
TipRanks
Go Ultimate75% OFF

Kristen Stants Insider Profile

4 Followers

Kristen Stants, CPO at Dianthus Therapeutics, holds 20.26K shares in Dianthus Therapeutics (Ticker: DNTH).

Kristen Stants's Trading History

DNTH
Dianthus Therapeutics
Dec 02, 2022CPOUninformative Buy2.82K$1.81M
DNTH
Insider Shares: 20.26K (0.03%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 02, 2022Uninformative Buy$2.82K3,000$0.94―
Jun 06, 2022Uninformative Buy$2.97K3,000$0.99―
Sep 20, 2021Informative Sell$38.60K5,736$6.73―
Sep 16, 2021Uninformative Buy$0.0020,000$0.00―

You May Also Like

Kristen Stants insider profile FAQ

What stocks does Kristen Stants hold?
Kristen Stants holds: DNTH stocks.
What was Kristen Stants’s latest transaction?
Kristen Stants’s latest transaction was an Uninformative Buy of $2.82K.
What is Kristen Stants's role in Dianthus Therapeutics?
Kristen Stants's role in Dianthus Therapeutics is CPO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.